"Uric Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
MeSH Number(s)
D03.132.960.877
D03.438.759.758.824.877
Concept/Terms
Uric Acid- Uric Acid
- Acid, Uric
- Trioxopurine
- 2,6,8-Trihydroxypurine
Sodium Urate Monohydrate- Sodium Urate Monohydrate
- Monohydrate, Sodium Urate
- Urate Monohydrate, Sodium
- Monosodium Urate Monohydrate
- Monohydrate, Monosodium Urate
- Urate Monohydrate, Monosodium
- Sodium Acid Urate Monohydrate
- Sodium Urate
- Urate, Sodium
- Monosodium Urate
- Urate, Monosodium
- Sodium Acid Urate
- Acid Urate, Sodium
- Urate, Sodium Acid
Below are MeSH descriptors whose meaning is more general than "Uric Acid".
Below are MeSH descriptors whose meaning is more specific than "Uric Acid".
This graph shows the total number of publications written about "Uric Acid" by people in Harvard Catalyst Profiles by year, and whether "Uric Acid" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 2 | 1 | 3 |
| 1996 | 1 | 1 | 2 |
| 1997 | 1 | 2 | 3 |
| 1998 | 1 | 1 | 2 |
| 1999 | 1 | 1 | 2 |
| 2000 | 2 | 0 | 2 |
| 2001 | 2 | 3 | 5 |
| 2002 | 1 | 0 | 1 |
| 2003 | 2 | 2 | 4 |
| 2004 | 5 | 3 | 8 |
| 2005 | 4 | 2 | 6 |
| 2006 | 6 | 1 | 7 |
| 2007 | 6 | 6 | 12 |
| 2008 | 14 | 5 | 19 |
| 2009 | 9 | 2 | 11 |
| 2010 | 11 | 6 | 17 |
| 2011 | 10 | 1 | 11 |
| 2012 | 15 | 12 | 27 |
| 2013 | 9 | 6 | 15 |
| 2014 | 19 | 12 | 31 |
| 2015 | 11 | 3 | 14 |
| 2016 | 13 | 7 | 20 |
| 2017 | 16 | 11 | 27 |
| 2018 | 13 | 5 | 18 |
| 2019 | 14 | 13 | 27 |
| 2020 | 11 | 16 | 27 |
| 2021 | 13 | 8 | 21 |
| 2022 | 5 | 20 | 25 |
| 2023 | 4 | 12 | 16 |
Below are the most recent publications written about "Uric Acid" by people in Profiles.
-
Effects of the DASH diet and losartan on serum urate among adults with hypertension: Results of a randomized trial. J Clin Hypertens (Greenwich). 2023 10; 25(10):915-922.
-
Comparative Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for Recurrent Gout Flares and Gout-Primary Emergency Department Visits and Hospitalizations : A General Population Cohort Study. Ann Intern Med. 2023 08; 176(8):1067-1080.
-
Clinical effects of a selective urate reabsorption inhibitor dotinurad in patients with hyperuricemia and treated hypertension: a multicenter, prospective, exploratory study (DIANA). Eur J Med Res. 2023 Jul 17; 28(1):238.
-
Prediagnostic Glycoprotein Acetyl Levels and Incident and Recurrent Flare Risk Accounting for Serum Urate Levels: A Population-Based, Prospective Study and Mendelian Randomization Analysis. Arthritis Rheumatol. 2023 09; 75(9):1648-1657.
-
Associations between Net Gastrointestinal Alkali Absorption, 24-Hour Urine Lithogenic Factors, and Kidney Stones. Clin J Am Soc Nephrol. 2023 08 01; 18(8):1068-1074.
-
Lowering Serum Urate With Urate-Lowering Therapy to Target and Incident Fracture Among People With Gout. Arthritis Rheumatol. 2023 08; 75(8):1456-1465.
-
Trends in Prevalence of Gout Among US Asian Adults, 2011-2018. JAMA Netw Open. 2023 04 03; 6(4):e239501.
-
Association of Dapagliflozin Use With Clinical Outcomes and the Introduction of Uric Acid-Lowering Therapy and Colchicine in Patients With Heart Failure With and Without Gout: A Patient-Level Pooled Meta-analysis of DAPA-HF and DELIVER. JAMA Cardiol. 2023 04 01; 8(4):386-393.
-
Comparative Safety of Gout Treatment Strategies on Cardiovascular Outcomes Using Observational Data: Clone-censor-weight Target Trial Emulation Approach. Epidemiology. 2023 07 01; 34(4):544-553.
-
Randomized trial of inosine for urate elevation in amyotrophic lateral sclerosis. Muscle Nerve. 2023 05; 67(5):378-386.